Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)
South Korea · Delayed Price · Currency is KRW 8,540.00
+20.00 (0.23%)
At close: Jul 10, 2026
Hwail Pharmaceutical Market Cap
Hwail Pharmaceutical has a market cap or net worth of 71.89 billion as of July 10, 2026. Its market cap has decreased by -19.67% in one year.
Market Cap
71.89B
Enterprise Value
n/a
Revenue
107.87B
Ranking
n/a
PE Ratio
18.00
Stock Price
8,540.00
Market Cap Chart
Since March 3, 2003, Hwail Pharmaceutical's market cap has increased from 24.67B to 71.89B, an increase of 191.34%. That is a compound annual growth rate of 4.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 71.89B | -26.01% |
| Dec 30, 2025 | 97.15B | -6.85% |
| Dec 30, 2024 | 104.30B | -27.25% |
| Dec 28, 2023 | 143.36B | -22.49% |
| Dec 29, 2022 | 184.96B | 7.56% |
| Dec 30, 2021 | 171.96B | -31.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 90.60B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 87.12B |
| KOREA PHARMA | 86.82B |
| Daehan Nupharm | 80.42B |
| Sam-A Pharm. | 78.24B |
| Polaris AI Pharma | 76.38B |
| Optipharm.CO.,LTD | 69.02B |
| Pharos iBio | 68.87B |